Pembrolizumab (pembro) vs paclitaxel (PTX) for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Phase 3 KEYNOTE-061 trial.
Tarih
2018Yazar
Fornaro, Lorenzo
Fuchs, Charles S.
Bang, Yung-Jue
Di Bartolomeo, Maria
Mandala, Mario
Ryu, Min-Hee
Olesinski, Tomasz
Caglevic, Christian
Chung, Hyun Cheol
Muro, Kei
Goekkurt, Eray
Mansoor, Wasat
McDermott, Raymond S.
Shacham-Shmueli, Einat
Chen, Xinqun
Kang, S. Peter
Mayo, Carlos Alberto
Ohtsu, Atsushi
Shitara, Kohei
Ozguroglu, Mustafa
Üst veri
Tüm öğe kaydını gösterBağlantı
http://hdl.handle.net/20.500.12627/108410https://doi.org/10.1200/jco.2018.36.15_suppl.4062
Koleksiyonlar
- Makale [92796]